Latest stories on TRVI
Trevi Therapeutics to Participate in Stifel's 2026 Healthcare Conference
Business Insider52 · neutralproduct/pr
Trevi Therapeutics to Participate in Stifel's 2026 Healthcare Conference
GlobeNewswire53 · neutralproduct/pr
Trevi Therapeutics Announces Oral Presentation Accepted at the CHEST 2026 Annual Meeting
Business Insider53 · neutralproduct/pr
Trevi Therapeutics Announces Oral Presentation Accepted at the CHEST 2026 Annual Meeting
GlobeNewswire56 · neutralproduct/pr
BMO reiterates Trevi Therapeutics stock rating after rival study fails
Investing.com Analyst Ratings63 · neutralanalyst
Trevi Therapeutics management to meet with Cantor
The Fly50 · neutralgeneral
Oppenheimer reiterates Trevi Therapeutics stock rating ahead of trial update
Investing.com Analyst Ratings56 · neutralanalyst
Trevi Therapeutics, Inc. (TRVI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Seeking Alpha56 · neutralgeneral
Trevi Therapeutics to Participate in Upcoming September Conferences
StockTitan56 · neutralgeneral
Trevi Therapeutics Announces Upcoming Presentations at the European Respiratory Society (ERS) Congress 2026
StockTitan56 · neutralproduct/pr
Trevi Therapeutics: A Specialty Beachhead Creates A Chronic Cough Platform
Seeking Alpha58 · neutralproduct/pr
Trevi Therapeutics price target raised to $28 from $24 at Jones
The Fly61 · neutralanalyst
Trevi Therapeutics Price Target Raised To 23 From 20 At Morgan Stanley
The Fly61 · neutralanalyst
Trevi Therapeutics price target raised to $40 from $27 at Raymond James
The Fly63 · neutralanalyst
Trevi Therapeutics Price Target Raised To 30 From 25 At Cantor Fitzgerald
The Fly61 · neutralanalyst
Trevi Therapeutics Price Target Raised To 25 From 24 At Oppenheimer
The Fly61 · neutralanalyst
Raymond James raises Trevi Therapeutics price target on pipeline progress
Investing.com Analyst Ratings63 · neutralanalyst
Trevi outlines 200+ global trial sites as it targets FDA alignment for non-IPF-ILD chronic cough in H2 2026
Seeking Alpha63 · neutralproduct/pr
Trevi Therapeutics, Inc. (TRVI) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Trevi Therapeutics Reports Q2 Eps 11c Consensus 11c
The Fly50 · neutralearnings
Trevi Therapeutics, Inc. (TRVI) files 8-K
SEC 8-K50 · neutralgeneral
Trevi Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates
StockTitan56 · neutralproduct/pr
Trevi Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026
Business Insider50 · neutralgeneral
Trevi Therapeutics to Participate in Upcoming August Conferences
StockTitan55 · neutralgeneral
BMO initiates Trevi Therapeutics stock at Outperform, $36 target
Investing.com Analyst Ratings61 · neutralanalyst